Selective Immune Suppression Using Interleukin-6 Receptor Inhibitors for Management of Immune-Related Adverse Events.
Faisal Fa'ak,Maryam Buni,Adewunmi Falohun,Huifang Lu,Juhee Song,Daniel H. Johnson,Chrystia M. Zobniw,Van A. Trinh,Muhammad Osama Awiwi,Nourel Hoda Tahon,Khaled M. Elsayes,Kaysia Ludford,Emma J. Montazari,Julia Chernis,Maya Dimitrova,Sabina Sandigursky,Jeffrey A. Sparks,Osama Abu-Shawer,Osama Rahma,Uma Thanarajasingam,Ashley M. Zeman,Rafee Talukder,Namrata Singh,Sarah H. Chung,Petros Grivas,May Daher,Ala Abudayyeh,Iman Osman,Jeffrey Weber,Jean H. Tayar,Maria E. Suarez-Almazor,Noha Abdel-Wahab,Adi Diab JOURNAL FOR IMMUNOTHERAPY OF CANCER（2023）
Key words
immune checkpoint inhibitors,autoimmunity,cytokines
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper